Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve BayStreet.ca - Wed Dec 18, 8:34AM CST

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 85.75 (-4.57%)
BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
GILD : 90.69 (-2.27%)
GOVX : 2.24 (-1.32%)
ARCT : 14.82 (-5.79%)
BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up Newswire.ca - Tue Dec 17, 6:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that in anticipation of...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
BioVaxys Shares New Data on its DPX™ Immune Educating Platform at Personalized Cancer Vaccine Summit Newswire.ca - Thu Dec 5, 6:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized Cancer...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
Can Emerging Agritech and Biotech Solutions Meet the World’s Food Security Demands? BayStreet.ca - Wed Nov 20, 8:59AM CST

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Reception to recent US election results has been mixed within the agriculture sector, with enthusiasm from some and...

CALM : 103.53 (-2.93%)
BVAXF : 0.0455 (+7.06%)
CTVA : 56.41 (-3.69%)
ELAN : 11.73 (-4.71%)
BIOV.CN : 0.0600 (unch)
ZTS : 167.01 (-2.21%)
BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY Newswire.ca - Wed Nov 20, 4:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce that...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium Newswire.ca - Tue Nov 5, 4:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems Newswire.ca - Thu Oct 31, 6:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024 Newswire.ca - Mon Oct 28, 7:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor Newswire.ca - Tue Oct 8, 6:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0455 (+7.06%)
BIOV.CN : 0.0600 (unch)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 11:39AM CDT

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0600 (unch)
BVAXF : 0.0455 (+7.06%)
BNTX : 111.61 (-4.92%)
CVAC : 2.75 (-6.78%)
VXRT : 0.5400 (-8.58%)
IBRX : 2.65 (-6.36%)

Barchart Exclusives

Stocks Climb Before the Open After Fed-Fueled Selloff, U.S. GDP Data and Nike Earnings on Tap Barchart - 1 hour ago
December S&P 500 E-Mini futures (ESZ24) are up +0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.52% this morning, partially rebounding from yesterday’s dramatic selloff after the Federal Reserve forecast fewer interest rate cuts next year, while investors awaited a raft of U.S. economic data and an earnings report from the world’s largest shoemaker Nike. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot